APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
Clinical trial NCT03537482 · RECRUITING
Trial details
- NCT number
- NCT03537482
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-07
- Primary completion
- 2024-09-15
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.